Atmosphere-ph.ru

Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru

ИНТЕРНЕТ-МАГАЗИН

Телефон издательства

Практическая пульмонология (ранее – "Атмосфера. Пульмонология и аллергология"): ISSN 2409-756X (Online), ISSN 2409-6636 (Print)
2018 / N 2

Поражения легких при системной реакции лекарственной гиперчувствительности с эозинофилией: обзор литературы и клинические наблюдения
И.И. Воржева, Б.А. Черняк

Список литературы
1. Cottin V. Eosinophilic lung diseases. Clinics in Chest Medicine 2016 Sep;37(3):535-56. 2. Drug-induced and iatrogenic respiratory disease. Camus P, Rosenow EC III, editors. London: MPG Books; 2010. 364 p.
3. Drug hypersensitivity. Pichler WJ, editor. Basel, Switzerland: Karger; 2007. 438 p.
4. Descamps V, Ranger-Rogez S. DRESS syndrome. Joint, Bone, Spine 2014 Jan;81(1):15-21.
5. Shiohara T, Kano Y. Drug reaction with eosinophilia and systemic symptoms (DRESS): incidence, pathogenesis and management. Expert Opinion on Drug Safety 2017 Feb;16(2):139-47.
6. Cho YT, Yang CW, Chu CY. Drug reaction with eosinophilia and systemic symptoms (DRESS): an interplay among drugs, viruses, and immune system. International Journal of Molecular Sciences 2017;18(6):1243.
7. Musette P, Janela B. New insights into drug reaction with eosinophilia and systemic symptoms pathophysiology. Frontiers in Medicine (Lausanne) 2017 Dec;4:179.
8. Criado PR, Avancini J, Santi CG, Medrado AT, Rodrigues CE, de Carvalho JF. Drug reaction with eosinophilia and systemic symptoms (DRESS): a complex interaction of drugs, viruses and the immune system. The Israel Medical Association Journal 2012 Sep;14(9):577-82.
9. The Drug-Induced Respiratory Disease website. Systemic reactions, syndromes and conditions (DRESS syndrome). Available from: http://www. pneumotox.com. Accessed 2018 Oct 03.
10. Jin H, Wang L, Ye J. Drug reaction with eosinophilia and systemic symptom in a patient with pneumonia and hyperthyroidism. Journal of Research in Pharmacy Practice 2017 Apr-Jun;6(2):130-3.
11. Suswardana, Hernanto M, Yudani BA, Pudjiati SR, Indrastuti N. DRESS syndrome from cefadroxil confirmed by positive patch test. Allergy 2007 Oct;62(10):1216-7.
12. Picard M, Fernandez MI, Des Roches A, Bégin P, Paradis J, Paradis L, Le Deist F. Ceftazidime-induced drug reaction with eosinophilia and systemic symptoms (DRESS) complicated by hemophagocytic lymphohistiocytosis. The Journal of Allergy and Clinical Immunology: In Practice 2013 Jul-Aug;1(4):409-12.
13. Nanishi E, Hoshina T, Ohga S, Nishio H, Hara T. Drug reaction with eosinophilia and systemic symptoms during primary Epstein-Barr virus infection. Journal of Microbiology, Immunology and Infection 2015;48(1):109-12.
14. Kang H, Min TK, Yang HJ, Pyun BY. Cefotaxime-induced drug rash with eosinophilia and systemic symptoms syndrome in a 7-year-old boy. Annals of Allergy, Asthma and Immunology 2016 Jun;117(2):202-4.
15. Wang L, Mei XL. Drug reaction with eosinophilia and systemic symptoms: retrospective analysis of 104 cases over one decade. Chinese Medical Journal (in English) 2017 Apr;130(8):943-9.
16. Sahnoun R, El Aïdli S, Zaïem A, Lakhoua G, Kastalli S, Daghfous R. DRESS syndrome induced by ciprofloxacine. Néphrologie & Thérapeutique 2015 Apr;11(2):111-3.
17. Chan L, Chan C, Cook DK. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: case report of severe multiorgan involvement to perindopril/amlodipine combination antihypertensive. JAAD Case Reports 2018 Jan;4(2):170-4.
18. Gressier L, Pruvost-Balland C, Dubertret L, Viguier M. Atorvastatin-induced drug reaction with eosinophilia and systemic symptoms (DRESS). Annales de Dermatologie et de Vénéréologie 2008 Nov;136(1):50-3.
19. Kardaun SH, Sekula P, Valeyrie-Allanore L, Liss Y, Chu CY, Creamer D, Sidoroff A, Naldi L, Mockenhaupt M, Roujeau JC; RegiSCAR study group. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Result from the prospective RegiSCAR study. The British Journal of Dermatology 2013 Nov;169(5):1071-80.
20. Pinto Gouveia M, Gameiro A, Coutinho I, Pereira N, Cardoso JC, Gonçalo M. Overlap between maculopapular exanthema and drug reaction with eosinophilia and systemic symptoms among cutaneous adverse drug reactions in a dermatology ward. The British Journal of Dermatology 2016 Dec;175(6):1274-83.
21. Husain Z, Reddy BY, Schwartz RA. DRESS syndrome: part 1. Clinical perspectives. Journal of the American Academy of Dermatology 2013 May;68(5):693.e1-14; quiz 706-8.
22. Thongsri T, Chularojanamontri L, Pichler WJ. Cardiac involvement in DRESS syndrome. Asian Pacific Journal of Allergy and Immunology 2017 Mar;35(1):3-10.
23. Wilcox O, Hassanein M, Armstrong J, Kassis N. Case report: atypical presentation of vancomycin induced DRESS syndrome: a case report and review of the literature. BMC Pulmonary Medicine 2017 Dec;17(1):217.
24. James J, Sammour YM, Virata AR, Nordin TA, Dumic I. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome secondary to furosemide: case report and review of literature. The American Journal of Case Reports 2018;19:163-70.
25.Воржева И.И. DRESS-синдром как одна из тяжелых форм лекарственной гиперчувствительности. Доктор.Ру. 2010;2:30-4.
26. Husain Z, Reddy BY, Schwartz RA. DRESS syndrome: Part II. Management and therapeutics. Journal of the American Academy of Dermatology 2013 May;68(5):709.e1-9; quiz 718-20.
27. Nam YH, Park MR, Nam HJ, Lee SK, Kim KH, Roh MS, Um SJ, Son CH. Drug reaction with eosinophilia and systemic symptoms syndrome is not uncommon and shows better clinical outcome than generally recognized. Allergologia et Immunopathologia (Madrid) 2015 Jan-Feb;43(1):19-24.
28. Oelze LL, Pillow MT. Phenytoin-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a case report from the emergency department. The Journal of Emergency Medicine 2013 Jan;44(1):75-8.
29. Kano Y, Tohyama M, Aihara M, Matsukura S, Watanabe H, Sueki H, Iijima M, Morita E, Niihara H, Asada H, Kabashima K, Azukizawa H, Hashizume H, Nagao K, Takahashi H, Abe R, Sotozono C, Kurosawa M, Aoyama Y, Chu CY, Chung WH, Shiohara T. Sequelae in 145 patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR). The Journal of Dermatology 2015 Mar;42(3):276-82.
30. Ushigome Y, Kano Y, Ishida T, Hirahara K, Shiohara T. Short- and long-term outcomes of 34 patients with drug-induced hypersensitivity syndrome in a single institution. Journal of the American Academy of Dermatology 2013 May;68(5):721-8.
31. Schrijvers R, Gilissen L, Chiriac AM, Demoly P. Pathogenesis and diagnosis of delayed type drug hypersensitivity reactions, from bedside to bench and back. Clinical and Translational Allergy 2015 Sep;5:31.
32. Muraro A, Lemanske RF Jr, Castells M, Torres MJ, Khan D, Simon HU, Bindslev-Jensen C, Burks W, Poulsen LK, Sampson HA, Worm M, Nadeau KC. Precision medicine in allergic disease-food allergy, drug allergy, and anaphylaxis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma and Immunology. Allergy 2017 Jul;72(7):1006-21.
33. Demoly P, Adkinson NF, Brockow K, Castells M, Chiriac AM, Greenberger PA, Khan DA, Lang DM, Park HS, Pichler W, Sanchez-Borges M, Shiohara T, Thong BY. International Consensus on drug allergy. Allergy 2014 Apr;69(4):420-37.
34. Brockow K, Garvey LH, Aberer W, Atanaskovic-Markovic M, Barbaud A, Bilo MB, Bircher A, Blanca M, Bonadonna B, Campi P, Castro E, Cernadas JR, Chiriac AM, Demoly P, Grosber M, Gooi J, Lombardo C, Mertes PM, Mosbech H, Nasser S, Pagani M, Ring J, Romano A, Scherer K, Schnyder B, Testi S, Torres M, Trautmann A, Terreehorst I; ENDA/EAACI Drug Allergy Interest Group. Skin test concentrations for systemically administered drugs – an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy 2013 Jun;68(6):702-12.

References
1. Cottin V. Eosinophilic lung diseases. Clinics in Chest Medicine 2016 Sep;37(3):535-56. 2. Drug-induced and iatrogenic respiratory disease. Camus P, Rosenow EC III, editors. London: MPG Books; 2010. 364 p.
3. Drug hypersensitivity. Pichler WJ, editor. Basel, Switzerland: Karger; 2007. 438 p.
4. Descamps V, Ranger-Rogez S. DRESS syndrome. Joint, Bone, Spine 2014 Jan;81(1):15-21.
5. Shiohara T, Kano Y. Drug reaction with eosinophilia and systemic symptoms (DRESS): incidence, pathogenesis and management. Expert Opinion on Drug Safety 2017 Feb;16(2):139-47.
6. Cho YT, Yang CW, Chu CY. Drug reaction with eosinophilia and systemic symptoms (DRESS): an interplay among drugs, viruses, and immune system. International Journal of Molecular Sciences 2017;18(6):1243.
7. Musette P, Janela B. New insights into drug reaction with eosinophilia and systemic symptoms pathophysiology. Frontiers in Medicine (Lausanne) 2017 Dec;4:179.
8. Criado PR, Avancini J, Santi CG, Medrado AT, Rodrigues CE, de Carvalho JF. Drug reaction with eosinophilia and systemic symptoms (DRESS): a complex interaction of drugs, viruses and the immune system. The Israel Medical Association Journal 2012 Sep;14(9):577-82.
9. The Drug-Induced Respiratory Disease website. Systemic reactions, syndromes and conditions (DRESS syndrome). Available from: http://www. pneumotox.com. Accessed 2018 Oct 03.
10. Jin H, Wang L, Ye J. Drug reaction with eosinophilia and systemic symptom in a patient with pneumonia and hyperthyroidism. Journal of Research in Pharmacy Practice 2017 Apr-Jun;6(2):130-3.
11. Suswardana, Hernanto M, Yudani BA, Pudjiati SR, Indrastuti N. DRESS syndrome from cefadroxil confirmed by positive patch test. Allergy 2007 Oct;62(10):1216-7.
12. Picard M, Fernandez MI, Des Roches A, Bégin P, Paradis J, Paradis L, Le Deist F. Ceftazidime-induced drug reaction with eosinophilia and systemic symptoms (DRESS) complicated by hemophagocytic lymphohistiocytosis. The Journal of Allergy and Clinical Immunology: In Practice 2013 Jul-Aug;1(4):409-12.
13. Nanishi E, Hoshina T, Ohga S, Nishio H, Hara T. Drug reaction with eosinophilia and systemic symptoms during primary Epstein-Barr virus infection. Journal of Microbiology, Immunology and Infection 2015;48(1):109-12.
14. Kang H, Min TK, Yang HJ, Pyun BY. Cefotaxime-induced drug rash with eosinophilia and systemic symptoms syndrome in a 7-year-old boy. Annals of Allergy, Asthma and Immunology 2016 Jun;117(2):202-4.
15. Wang L, Mei XL. Drug reaction with eosinophilia and systemic symptoms: retrospective analysis of 104 cases over one decade. Chinese Medical Journal (in English) 2017 Apr;130(8):943-9.
16. Sahnoun R, El Aïdli S, Zaïem A, Lakhoua G, Kastalli S, Daghfous R. DRESS syndrome induced by ciprofloxacine. Néphrologie & Thérapeutique 2015 Apr;11(2):111-3.
17. Chan L, Chan C, Cook DK. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: case report of severe multiorgan involvement to perindopril/amlodipine combination antihypertensive. JAAD Case Reports 2018 Jan;4(2):170-4.
18. Gressier L, Pruvost-Balland C, Dubertret L, Viguier M. Atorvastatin-induced drug reaction with eosinophilia and systemic symptoms (DRESS). Annales de Dermatologie et de Vénéréologie 2008 Nov;136(1):50-3.
19. Kardaun SH, Sekula P, Valeyrie-Allanore L, Liss Y, Chu CY, Creamer D, Sidoroff A, Naldi L, Mockenhaupt M, Roujeau JC; RegiSCAR study group. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Result from the prospective RegiSCAR study. British Journal of Dermatology 2013 Nov;169(5):1071-80.
20. Pinto Gouveia M, Gameiro A, Coutinho I, Pereira N, Cardoso JC, Gonçalo M. Overlap between maculopapular exanthema and drug reaction with eosinophilia and systemic symptoms among cutaneous adverse drug reactions in a dermatology ward. British Journal of Dermatology 2016 Dec;175(6):1274-83.
21. Husain Z, Reddy BY, Schwartz RA. DRESS syndrome: part 1. Clinical perspectives. Journal of the American Academy of Dermatology 2013 May;68(5):693.e1-14; quiz 706-8.
22. Thongsri T, Chularojanamontri L, Pichler WJ. Cardiac involvement in DRESS syndrome. Asian Pacific Journal of Allergy and Immunology 2017 Mar;35(1):3-10.
23. Wilcox O, Hassanein M, Armstrong J, Kassis N. Case report: atypical presentation of vancomycin induced DRESS syndrome: a case report and review of the literature. BMC Pulmonary Medicine 2017 Dec;17(1):217.
24. James J, Sammour YM, Virata AR, Nordin TA, Dumic I. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome secondary to furosemide: case report and review of literature. The American Journal of Case Reports 2018;19:163-70.
25. Vorzheva II. DRESS syndrome as one of severe forms of drug hypersensitivity. Doctor.Ru. 2010;2(53):32-6 (In Russian).
26. Husain Z, Reddy BY, Schwartz RA. DRESS syndrome: Part II. Management and therapeutics. Journal of the American Academy of Dermatology 2013 May;68(5):709.e1-9; quiz 718-20.
27. Nam YH, Park MR, Nam HJ, Lee SK, Kim KH, Roh MS, Um SJ, Son CH. Drug reaction with eosinophilia and systemic symptoms syndrome is not uncommon and shows better clinical outcome than generally recognized. Allergologia et Immunopathologia (Madrid) 2015 Jan-Feb;43(1):19-24.
28. Oelze LL, Pillow MT. Phenytoin-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a case report from the emergency department. The Journal of Emergency Medicine 2013 Jan;44(1):75-8.
29. Kano Y, Tohyama M, Aihara M, Matsukura S, Watanabe H, Sueki H, Iijima M, Morita E, Niihara H, Asada H, Kabashima K, Azukizawa H, Hashizume H, Nagao K, Takahashi H, Abe R, Sotozono C, Kurosawa M, Aoyama Y, Chu CY, Chung WH, Shiohara T. Sequelae in 145 patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR). The Journal of Dermatology 2015 Mar;42(3):276-82.
30. Ushigome Y, Kano Y, Ishida T, Hirahara K, Shiohara T. Short- and long-term outcomes of 34 patients with drug-induced hypersensitivity syndrome in a single institution. Journal of the American Academy of Dermatology 2013 May;68(5):721-8.
31. Schrijvers R, Gilissen L, Chiriac AM, Demoly P. Pathogenesis and diagnosis of delayed type drug hypersensitivity reactions, from bedside to bench and back. Clinical and Translational Allergy 2015 Sep;5:31.
32. Muraro A, Lemanske RF Jr, Castells M, Torres MJ, Khan D, Simon HU, Bindslev-Jensen C, Burks W, Poulsen LK, Sampson HA, Worm M, Nadeau KC. Precision medicine in allergic disease-food allergy, drug allergy, and anaphylaxis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma and Immunology. Allergy 2017 Jul;72(7):1006-21.
33. Demoly P, Adkinson NF, Brockow K, Castells M, Chiriac AM, Greenberger PA, Khan DA, Lang DM, Park HS, Pichler W, Sanchez-Borges M, Shiohara T, Thong BY. International Consensus on drug allergy. Allergy 2014 Apr;69(4):420-37.
34. Brockow K, Garvey LH, Aberer W, Atanaskovic-Markovic M, Barbaud A, Bilo MB, Bircher A, Blanca M, Bonadonna B, Campi P, Castro E, Cernadas JR, Chiriac AM, Demoly P, Grosber M, Gooi J, Lombardo C, Mertes PM, Mosbech H, Nasser S, Pagani M, Ring J, Romano A, Scherer K, Schnyder B, Testi S, Torres M, Trautmann A, Terreehorst I; ENDA/EAACI Drug Allergy Interest Group. Skin test concentrations for systemically administered drugs – an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy 2013 Jun;68(6):702-12.

[ Содержание выпуска N 2 | Выпуски журнала | Список журналов ]